BR9911941A - Composição contento no mìnimo uma substância ativa tendo uma influência sobre os nìveis de lipìdeos no sangue - Google Patents

Composição contento no mìnimo uma substância ativa tendo uma influência sobre os nìveis de lipìdeos no sangue

Info

Publication number
BR9911941A
BR9911941A BR9911941-2A BR9911941A BR9911941A BR 9911941 A BR9911941 A BR 9911941A BR 9911941 A BR9911941 A BR 9911941A BR 9911941 A BR9911941 A BR 9911941A
Authority
BR
Brazil
Prior art keywords
active substance
influence
composition containing
blood lipid
lipid levels
Prior art date
Application number
BR9911941-2A
Other languages
English (en)
Inventor
Achim Berthold
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BR9911941A publication Critical patent/BR9911941A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO CONTENDO NO MìNIMO UMA SUBSTâNCIA ATIVA TENDO UMA INFLUêNCIA SOBRE OS NìVEIS DE LIPìDEOS NO SANGUE"<D>. é caracterizada uma preparação contendo no mínimo uma substância ativa tendo uma influência sobre os níveis sang³íneos de lipídeos de um organismo em que está presente sob a forma de um emplastro terapêutico transdérmico contendo a substância ativa em uma camada de matriz auto-aderente a qual pode ser coberta no lado oposto à pele com uma camada de revestimento posterior impermeável à substância ativa.
BR9911941-2A 1998-07-09 1999-07-07 Composição contento no mìnimo uma substância ativa tendo uma influência sobre os nìveis de lipìdeos no sangue BR9911941A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830732A DE19830732B4 (de) 1998-07-09 1998-07-09 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
PCT/EP1999/004757 WO2000002541A1 (de) 1998-07-09 1999-07-07 Transdermales pflaster, enthaltend mindestens einen die blutfettwerte beeinflussenden wirkstoff

Publications (1)

Publication Number Publication Date
BR9911941A true BR9911941A (pt) 2001-03-27

Family

ID=7873488

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911941-2A BR9911941A (pt) 1998-07-09 1999-07-07 Composição contento no mìnimo uma substância ativa tendo uma influência sobre os nìveis de lipìdeos no sangue

Country Status (22)

Country Link
EP (1) EP1094797B1 (pt)
JP (1) JP2002520272A (pt)
KR (1) KR100549848B1 (pt)
CN (1) CN1309377C (pt)
AR (1) AR019902A1 (pt)
AT (1) ATE278395T1 (pt)
AU (1) AU770573B2 (pt)
BR (1) BR9911941A (pt)
CA (1) CA2336712C (pt)
CZ (1) CZ300976B6 (pt)
DE (2) DE19830732B4 (pt)
ES (1) ES2230872T3 (pt)
HU (1) HU226614B1 (pt)
IL (2) IL140667A0 (pt)
MX (1) MXPA01000126A (pt)
NZ (1) NZ509215A (pt)
PL (1) PL194983B1 (pt)
RU (1) RU2227023C2 (pt)
TR (1) TR200100021T2 (pt)
TW (1) TWI237572B (pt)
WO (1) WO2000002541A1 (pt)
ZA (1) ZA200100171B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189890B1 (pl) * 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparat do ochrony roślin przed chorobami
WO2004026297A1 (ja) * 2002-09-20 2004-04-01 Kowa Co., Ltd. 外用剤
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
AU2004203700B2 (en) * 2003-01-02 2007-06-21 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
WO2005094814A1 (ja) * 2004-03-31 2005-10-13 Kowa Co., Ltd. 外用剤
JP4986411B2 (ja) * 2004-06-01 2012-07-25 久光製薬株式会社 貼付剤
US8173155B2 (en) 2004-06-01 2012-05-08 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
US20050281868A1 (en) * 2004-06-21 2005-12-22 Fairfield Clinical Trials, Llc Transdermal delivery system for statin combination therapy
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
CA2644851A1 (en) * 2006-03-07 2007-09-13 Osteoscreen Ip, Llc Hmg co-a reductase inhibitor enhancement of bone and cartilage
KR100817274B1 (ko) * 2006-08-21 2008-03-27 삼성전기주식회사 발광 다이오드 패키지 및 그 제조방법
WO2018115535A1 (es) 2016-12-19 2018-06-28 Nutritape, S.L. Parche energizante para deportistas
CN113573794B (zh) * 2019-03-12 2023-06-16 康宁股份有限公司 具有表皮的陶瓷蜂窝体
TWI803052B (zh) * 2021-11-12 2023-05-21 佛教慈濟醫療財團法人 經皮遞送裝置及其使用及製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
DE69524614T2 (de) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co., Inc. Arzneimittelbestandteile einschliesslich eines n-substituierten o-toluidinderivats und transdermal absorbierbare zubereitung
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
WO1999024032A1 (en) * 1997-11-10 1999-05-20 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans

Also Published As

Publication number Publication date
IL140667A (en) 2007-05-15
EP1094797A1 (de) 2001-05-02
RU2227023C2 (ru) 2004-04-20
CA2336712C (en) 2008-09-09
ES2230872T3 (es) 2005-05-01
DE19830732B4 (de) 2008-11-13
PL194983B1 (pl) 2007-07-31
NZ509215A (en) 2003-04-29
TR200100021T2 (tr) 2001-05-21
AR019902A1 (es) 2002-03-20
TWI237572B (en) 2005-08-11
ATE278395T1 (de) 2004-10-15
EP1094797B1 (de) 2004-10-06
JP2002520272A (ja) 2002-07-09
IL140667A0 (en) 2002-02-10
MXPA01000126A (es) 2002-06-04
WO2000002541A1 (de) 2000-01-20
CN1309377C (zh) 2007-04-11
PL345510A1 (en) 2001-12-17
AU770573B2 (en) 2004-02-26
CN1308525A (zh) 2001-08-15
HU226614B1 (en) 2009-04-28
HUP0102718A3 (en) 2002-12-28
HUP0102718A2 (hu) 2002-03-28
DE19830732A1 (de) 2000-01-13
DE59910758D1 (de) 2004-11-11
CZ200193A3 (en) 2001-05-16
KR100549848B1 (ko) 2006-02-06
KR20010079513A (ko) 2001-08-22
CA2336712A1 (en) 2000-01-20
ZA200100171B (en) 2001-08-10
CZ300976B6 (cs) 2009-09-30
AU5157499A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
BR9911941A (pt) Composição contento no mìnimo uma substância ativa tendo uma influência sobre os nìveis de lipìdeos no sangue
De Berker et al. Disorders of nails
FNLAY Pharmacokinetics of terbinafine in the nail
CA2303394C (en) A delivery of arginine to cause beneficial effects
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
ES2586860T3 (es) Cuerpo laminado de parche cutáneo
KR20010040785A (ko) 손톱(발톱)진균증의 치료를 위한 압력 민감성접착메트릭스 패치
PT95014A (pt) Dispositivo bifasico de distribuicao transdermicarnadermica
BR0009632A (pt) Artigo absorvente
NO904338L (no) Fremgangsmaate for fremstilling av et plaster med oestrogenholdige virksomme stoffer.
ES491621A0 (es) Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal.
NO20002487D0 (no) Preparat med azelainsyre
ES2372959T3 (es) Analgésico anti-inflamatorio para uso externo.
Marks et al. Common Skin Diseases 18th edition
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
ES2291559T3 (es) Aplicacion topica de esteres de vitamina e.
BRPI0505988A (pt) formulação cosmética e/ou dermtólogica e uso da mesma
DK1615628T3 (da) Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden
Varma et al. Dermatomyositis‐like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis
KR950015055B1 (ko) 활성성분으로서 노르슈도에페드린을 함유하는 경피 치료용 시스템
Kuokkanen et al. Parakeratotic horns in a patient with myeloma
Abdel-Naser et al. Common dermatoses in moderately pigmented skin: uncommon presentations
BR0212506A (pt) Administração transdérmica de um éster de enalapril
Veraldi et al. Leishmaniasis of the lip
NO784025L (no) Antiperspirant.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61F 13/02, A61K 9/70, A61K 31/366, A61K 47/30, A61P 3/06, A61P 9/10

Ipc: A61K 9/70 (2008.04), A61K 31/366 (2008.04)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O E ART. 13 DA LPI ) AS REIVINDICACOES ESTAO INDEFINIDAS E/OU NAO ESTAO FUNDAMENTADAS NO RELATORIO DESCRITIVO ( ART. 25 DA LPI )

B12B Appeal against refusal [chapter 12.2 patent gazette]